Roche declines comment on Illumina interest

ZURICH Tue Oct 16, 2012 2:28am EDT

ZURICH Oct 16 (Reuters) - Swiss drugmaker Roche Holding AG d eclined to comment on Tuesday on market talk it m ight reconsider its bid for U.S. gene-sequencing company Illumina.

Chief Executive Severin Schwan told a conference call for journalists he would not comment on market rumours.

Roche dropped a $6.8 billion hostile takeover bid for the company i n April a fter shareholders blocked its move to gain seats on the company's board.

Earlier on Tuesday, Roche reported third-quarter sales rose 15 percent to 11.271 billion Swiss francs ($12.07 billion), beating the average analyst forecast of 11.124 billion francs in a Reuters poll.

A couple walks along the rough surf during sunset at Oahu's North Shore, December 26, 2013. REUTERS/Kevin Lamarque

Find your dream retirement town

Florida? Hawaii? Reuters has teamed up with Zillow to give you the power to customize a list of your best places to retire.  Video | Full Article